Research and development strategies of new Chinese medicines based on new regulations / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 3150-3155, 2021.
Article
en Zh
| WPRIM
| ID: wpr-888055
Biblioteca responsable:
WPRO
ABSTRACT
In recent years, only a small number of new Chinese medicines have been approved for marketing, which has embodied the bottleneck in the development of the Chinese medicine industry. To tackle this problem, the National Medical Products Administration has issued a series of regulations and technical requirements. In the context of new regulations, this study deeply explored the research and development strategies of new Chinese medicines under the guidance of the new classification of drug registration, and discussed the key technical issues in the research and development.
Palabras clave
Texto completo:
1
Bases de datos:
WPRIM
Medicinas Tradicionales:
Medicinas_tradicionales_de_asia
/
Medicina_china
Métodos Terapéuticos y Terapias MTCI:
Terapias_biologicas
Asunto principal:
Investigación
/
Medicamentos Herbarios Chinos
/
Preparaciones Farmacéuticas
/
China
/
Medicina Tradicional China
Tipo de estudio:
Diagnostic_studies
País/Región como asunto:
Asia
Idioma:
Zh
Revista:
China Journal of Chinese Materia Medica
Año:
2021
Tipo del documento:
Article